Key Highlights
- $3.5M series seed funding led by Silverton Partners.
- mpVision scales GxP-compatible AI models for real-time quality control.
- Reduces industry QC failures costing $50 billion annually.
- CEO Taylor Chartier to create AI Good Practice Guide for ISPE.
- Over 1000 registrants for ISPE’s GxP AI Webinar Series.
Source: PR Newswire
Notable Quotes
- “When the Modicus Prime team meets with scientists and automation teams at pharma companies, we usually hear about long assay and software turnaround times limiting their ability to take immediate action during commercial production. In response, pharmaceutical domain experts guided the construction of mpVision’s cloud ecosystem to be their natural quality control solution.” — Taylor Chartier, CEO at Modicus Prime
- “This company is responding to the pharmaceutical industry’s current demands, delivering a welcomed cloud technology that’s already yielding practical results. We are very enthusiastic about supporting this movement.” — Roger Chen, Partner at Silverton Partners
SoHC's Take
Modicus Prime’s successful seed funding marks a significant advancement in the realm of pharmaceutical manufacturing quality control. The mpVision technology’s ability to scale GxP-compatible AI models across various devices ensures real-time quality assurance, addressing the critical need for in-process monitoring as urged by regulatory bodies like the FDA. The anticipated AI Good Practice Guide and the GxP AI Webinar Series led by CEO Taylor Chartier further solidify Modicus Prime’s pivotal role in guiding the industry towards efficient and reliable AI integration. This funding not only bolsters Modicus Prime’s growth but also underscores the industry’s confidence in innovative solutions that promise to reduce the staggering costs associated with quality control failures.
